Cellular Therapeutics (United Kingdom)

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

Partow Kebriaei, Harjeet Singh, M. Helen Huls et al. · Journal of Clinical Investigation · 2016 · 494 citations · Full text

Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study

Martin J. Elliott, Paolo De Coppi, Simone Speggiorin et al. · The Lancet · 2012 · 469 citations

Tissue Engineering, Regenerative Medicine, 2-Year Follow-up Study +13

Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell Transplantation

Joseph R. Leventhal, Michaël Abécassis, Joshua Miller et al. · Science Translational Medicine · 2012 · 465 citations · Full text

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

John P. Chute, Garrett G. Muramoto, John G. Whitesides et al. · Proceedings of the National Academy of Sciences · 2006 · 462 citations · Full text

Developmental Biology, Cell Regulation, Aldehyde Dehydrogenase +14

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

Fiona Thistlethwaite, David E. Gilham, Ryan D. Guest et al. · Cancer Immunology Immunotherapy · 2017 · 395 citations · Full text